Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
229. lappuse
... assay in § 448.513f ( b ) . ( c ) Chlortetracycline hydrochloride ointment containing , in each gram , 30 milligrams of chlortetracycline hydro- chloride in a suitable ointment base : Provided , That it meets the tests and methods of assay ...
... assay in § 448.513f ( b ) . ( c ) Chlortetracycline hydrochloride ointment containing , in each gram , 30 milligrams of chlortetracycline hydro- chloride in a suitable ointment base : Provided , That it meets the tests and methods of assay ...
230. lappuse
... assay in § 448.513b ( b ) . ( 5 ) Bacitracin zinc - neomycin sulfate- polymyxin B sulfate ointment contain- ing , in each gram , in a suitable oint- ment base the following : ( i ) 400 units of bacitracin , 3 milli- grams of neomycin ...
... assay in § 448.513b ( b ) . ( 5 ) Bacitracin zinc - neomycin sulfate- polymyxin B sulfate ointment contain- ing , in each gram , in a suitable oint- ment base the following : ( i ) 400 units of bacitracin , 3 milli- grams of neomycin ...
351. lappuse
... Assay Methods 436.100 Laboratory equipment . 436.101 436.102 Solutions . Culture media . 436.103 Test organisms . 436.104 Penicillin activity . 436.105 Microbiological agar diffusion assay . 436.106 Microbiological turbidimetric assay ...
... Assay Methods 436.100 Laboratory equipment . 436.101 436.102 Solutions . Culture media . 436.103 Test organisms . 436.104 Penicillin activity . 436.105 Microbiological agar diffusion assay . 436.106 Microbiological turbidimetric assay ...
352. lappuse
... assay for moxalactam . 436.333 Thin layer chromatographic identity 436.336 Thin layer chromatographic identity 436.344 Thin layer chromatographic identity free erythromycin content in erythro- mycin estolate bulk . 436.363 High ...
... assay for moxalactam . 436.333 Thin layer chromatographic identity 436.336 Thin layer chromatographic identity 436.344 Thin layer chromatographic identity free erythromycin content in erythro- mycin estolate bulk . 436.363 High ...
462. lappuse
... assay . Add the indicated amount of dis- tilled water to the contents of a vial of the sample , and shake well ... assay of approximately 2,000 units per milli- liter . ( 2 ) Iodometric assay for total penicillin in the solution for ...
... assay . Add the indicated amount of dis- tilled water to the contents of a vial of the sample , and shake well ... assay of approximately 2,000 units per milli- liter . ( 2 ) Iodometric assay for total penicillin in the solution for ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning